| dc.contributor.author | Kalpaklioglu, Ayse Fusun | |
| dc.contributor.author | Kavut, Ayse Baccioglu | |
| dc.contributor.author | Erdemoglu, Ali Kemal | |
| dc.date.accessioned | 2020-06-25T17:48:49Z | |
| dc.date.available | 2020-06-25T17:48:49Z | |
| dc.date.issued | 2009 | |
| dc.identifier.citation | closedAccess | en_US |
| dc.identifier.issn | 1018-2438 | |
| dc.identifier.issn | 1423-0097 | |
| dc.identifier.uri | https://doi.org/10.1159/000189203 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12587/4569 | |
| dc.description | WOS: 000263355000014 | en_US |
| dc.description | PubMed: 19127077 | en_US |
| dc.description.abstract | We report a 41-year-old patient with multiple sclerosis (MS) who was successfully desensitized after she developed non-injection-site urticaria and angioedema due to interferon (IFN)-beta 1a. Although a few cases of urticaria and anaphylaxis have been reported in the literature, to our knowledge this is the first report of a successful desensitization with IFN-beta 1a. Desensitization with IFN-beta 1a allowed us to continue with the administration of interferon-beta, which is a mainstay in treatment for MS. Copyright (C) 2009 S. Karger AG, Basel | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Karger | en_US |
| dc.relation.isversionof | 10.1159/000189203 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Desensitization | en_US |
| dc.subject | Drug allergy | en_US |
| dc.subject | Interferon | en_US |
| dc.title | Desensitization in Interferon-beta 1a Allergy: A Case Report | en_US |
| dc.type | article | en_US |
| dc.contributor.department | Kırıkkale Üniversitesi | en_US |
| dc.identifier.volume | 149 | en_US |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.startpage | 178 | en_US |
| dc.identifier.endpage | 180 | en_US |
| dc.relation.journal | International Archives Of Allergy And Immunology | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
